Related Experiment Videos
Congenital diaphragmatic hernia
Nicola P Smith1, Edwin C Jesudason, Paul D Losty
1Institute of Child Health, University of Liverpool, Alder Hey Children's Hospital, Eaton Road, Liverpool L12 2AP, UK.
Insights
Congenital diaphragmatic hernia (CDH) is a severe birth defect causing underdeveloped lungs and high mortality. Research now suggests a primary lung development defect in CDH, not just compression, offering new therapeutic avenues.
Area of Science:
- Developmental Biology
- Pediatric Surgery
- Neonatology
Background:
- Congenital diaphragmatic hernia (CDH) is a critical human birth defect with a 30-50% mortality rate.
- Lung hypoplasia, or underdeveloped lungs, is the primary cause of mortality in infants with CDH.
- Current management strategies include fetal surgery, specialized intensive care, and planned delivery.
Purpose of the Study:
- To explore the underlying causes of lung hypoplasia in congenital diaphragmatic hernia.
- To investigate emerging evidence for a primary defect in lung development in CDH.
- To identify potential new therapeutic targets for improving outcomes in CDH patients.
Main Methods:
- Review of experimental evidence regarding lung development in CDH.
- Utilizing cell culture systems to study lung hypoplasia.
- Investigating the role of growth factors and signaling pathways in CDH lung development.
Main Results:
- Emerging evidence suggests a primary defect in lung development in CDH, challenging the traditional view of secondary compression.
- Culture systems provide valuable tools for studying lung hypoplasia and associated molecular mechanisms.
- Similarities with premature lungs suggest potential benefits from antenatal corticosteroids.
Conclusions:
- A primary defect in lung development is increasingly implicated in congenital diaphragmatic hernia.
- Further understanding of lung development biology is crucial for advancing CDH care.
- Potential advancements include antenatal corticosteroids and improved postnatal therapies like permissive hypercapnia and liquid ventilation.
Abstract:
Congenital diaphragmatic hernia (CDH) is a lethal human birth defect. Hypoplastic lung development is the leading contributor to its 30-50% mortality rate. Efforts to improve survival have focused on fetal surgery, advances in intensive care and elective delivery at specialist centres following in utero diagnosis. The impact of abnormal lung development on affected infants has stimulated research into the developmental biology of CDH. Traditionally lung hypoplasia has been viewed as a secondary consequence of in utero compression of the fetal lung. Experimental evidence is emerging for a primary defect in lung development in CDH. Culture systems are providing research tools for the study of lung hypoplasia and the investigation of the role of growth factors and signalling pathways. Similarities between the lungs of premature newborns and infants with CDH may indicate a role for antenatal corticosteroids. Further advances in postnatal therapy including permissive hypercapnia and liquid ventilation hold promise. Improvements in our basic scientific understanding of lung development may hold the key to future developments in CDH care.